皇氏集团股份有限公司 公司章程 皇氏集团股份有限公司 章 程 二〇二五年四月 1 | 第一章 | 总则 3 | | --- | --- | | 第二章 | 经营宗旨和范围 4 | | 第三章 | 股份 4 | | 第一节 | 股份发行 4 | | 第二节 | 股份增减和回购 5 | | 第三节 | 股份转让 6 | | 第四章 | 股东和股东大会 7 | | 第一节 | 股东 7 | | 第二节 | 股东大会的一般规定 9 | | 第三节 | 股东大会的召集 12 | | 第四节 | 股东大会的提案与通知 14 | | 第五节 | 股东大会的召开 15 | | 第六节 | 股东大会的表决和决议 18 | | 第五章 | 董事会 23 | | 第一节 | 董事 23 | | 第二节 | 董事会 26 | | 第三节 | 董事会专门委员会 30 | | 第六章 | 总裁及其他高级管理人员 31 | | 第七章 | 监事会 32 | | 第一节 | 监事 32 | | 第二节 | 监事会 33 | | 第八章 | 财务会计制度、利润分配和审计 35 | | 第一节 | 财务会计制度 35 | | 第二节 | 利润分 ...

证券代码：002329 证券简称：皇氏集团 公告编号：2025–041 皇氏集团股份有限公司 关于 2025 年度担保额度预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 皇氏集团股份有限公司（以下简称"公司"）及控股子公司对外担保总额已 超过最近一期经审计净资产的 100%，本次担保含公司及子公司对资产负债率超 过 70%的子公司提供担保，本次担保额度预计金额已超过公司最近一期经审计净 资产的 50%。请投资者注意担保风险。 一、担保情况概述 根据公司及子公司业务发展、生产经营等需求，预计 2025 年度公司拟为子 公司（含子公司之间）、子公司为公司等主体提供担保的额度合计为不超过人民 币 331,816.00 万元，该担保额度可循环使用，最终实际担保总额不超过本次审批 的担保额度，其中：为资产负债率大于或等于 70%的子公司提供担保额度不超过 68,900.00 万元，为资产负债率低于 70%的子公司提供担保额度不超过 241,216.00 万元，本次担保有效期为公司 2024 年度股东大会审议通过之日起的十二个月内。 本次担保预计的 ...

证券代码：002329 证券简称：皇氏集团 公告编号：2025–040 皇氏集团股份有限公司 关于减少注册资本、修订《公司章程》 暨通知债权人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 2025 年 4 月 29 日，皇氏集团股份有限公司（以下简称"公司"）召开 第七届董事会第三次会议和第七届监事会第三次会议，审议通过了《关于减少 注册资本、修订〈公司章程〉暨通知债权人的议案》。 因部分限制性股票及业绩承诺补偿股份回购注销，公司股份总数将由 853,044,615 股变更为 832,403,985 股，公司注册资本将由 853,044,615 元变更为 832,403,985 元，该议案尚需提请公司 2024 年度股东大会审议。现将相关情况 公告如下： 一、注册资本减少情况 （一）限制性股票回购注销 鉴于公司 2022 年限制性股票激励计划第一个解除限售期（2023 年度）公 司层面业绩考核目标未达标以及首次授予部分激励对象因个人原因离职、退休 或其原任职的子公司已不再纳入公司合并报表范围，已不符合激励条件，根据 《上市公司股权激励管理办法》《深圳 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：002329 证券简称：皇氏集团 公告编号：2025-042 皇氏集团股份有限公司 关于召开 2024 年度股东大会的通知 一、召开会议的基本情况 1．股东大会届次：2024 年度股东大会 2．股东大会的召集人：公司董事会 2025 年 4 月 29 日，公司第七届董事会第三次会议审议通过了《关于召开公 司 2024 年度股东大会的议案》。 3．会议召开的合法、合规性：本次股东大会会议的召开符合《公司法》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等有关 法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 4．会议召开的日期、时间： （1）现场会议时间：2025年5月21日（星期三），下午14:30-15:30 （2）网络投票时间： ①深圳证券交易所（以下简称"深交所"）交易系统网络投票时间：2025 年5月21日上午9:15-9:25，9:30-11:30，下午13:00-15:00； ②深交所互联网投票系统（http://wltp.cninfo.com.cn）投 ...

证券代码：002329 证券简称：皇氏集团 公告编号：2025-039 皇氏集团股份有限公司 第七届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、监事会会议审议情况 会议审议并以记名投票的方式表决通过了如下议案： （一）皇氏集团股份有限公司 2025 年第一季度报告 经审议，监事会认为：公司 2025 年第一季度报告的内容真实、准确、完整 地反映了公司 2025 年第一季度经营的实际情况，不存在虚假记载、误导性陈述 或者重大遗漏，报告编制和审核的程序符合法律、行政法规和中国证监会的相关 规定。 详见公司同日登载于《中国证券报》《证券时报》《上海证券报》《证券日 报》及巨潮资讯网（http://www.cninfo.com.cn）上的《2025 年第一季度报告》（公 1 告编号：2025-037）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 （二）关于减少注册资本、修订《公司章程》暨通知债权人的议案 一、监事会会议召开情况 2025 年 4 月 29 日，皇氏集团股份有限公司（以下简称"公司"）第七届监 事会第三次会议 ...

2025 年 4 月 29 日，皇氏集团股份有限公司（以下简称"公司"）第七届董 事会第三次会议在公司会议室以现场方式召开。会议通知以书面及微信等方式于 2025 年 4 月 18 日发出。应参加会议的董事 9 人，实际参加会议的董事 9 人。会 议由董事长黄嘉棣先生主持，公司监事及其他高级管理人员列席了会议。会议符 合《公司法》和《公司章程》的有关规定。 第七届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 二、董事会会议审议情况 会议审议并以记名投票的方式表决通过了如下议案： （一）皇氏集团股份有限公司 2025 年第一季度报告 证券代码：002329 证券简称：皇氏集团 公告编号：2025–038 皇氏集团股份有限公司 经审议，董事会认为：公司 2025 年第一季度报告的内容真实、准确、完整 地反映了公司 2025 年第一季度经营的实际情况，不存在虚假记载、误导性陈述 或者重大遗漏，报告编制和审核的程序符合法律、行政法规和中国证监会的相关 规定。 详见公司同日登载于《中国证券报》《证券时报》《上海证券报》 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥446,486,599.34, a decrease of 6.90% compared to ¥479,590,062.08 in the same period last year[4] - Net profit attributable to shareholders increased by 10.05% to ¥5,683,390.02 from ¥5,164,539.65 year-on-year[4] - The net profit after deducting non-recurring gains and losses surged by 136.46%, reaching ¥2,385,522.10, compared to a loss of ¥6,542,646.54 in the previous year[4] - The net profit for the current period is 6,891,355.29, an increase of 44.4% compared to 4,774,138.06 in the previous period[18] - The total comprehensive income for the current period is 7,155,299.63, up from 5,496,163.79, reflecting a growth of 30.2%[18] - The basic earnings per share increased to 0.0068 from 0.0062, representing a growth of 9.7%[18] - The operating profit for the current period is 9,175,732.56, an increase of 42.2% compared to 6,452,871.48 in the previous period[18] Cash Flow - The net cash flow from operating activities was negative at -¥83,808,559.32, worsening by 22.00% from -¥68,694,071.51 in the same period last year[4] - Cash flow from operating activities showed a net outflow of -83,808,559.32, compared to -68,694,071.51 in the previous period, indicating a decline in operational cash flow[19] - Cash flow from investing activities resulted in a net outflow of -116,664,009.71, worsening from -35,585,851.84 in the previous period[20] - Cash flow from financing activities generated a net inflow of 147,912,897.32, compared to 133,922,447.43 in the previous period, showing an increase of 10.5%[20] - The total revenue from sales of goods and services received cash of 460,110,387.79, down from 711,240,408.24, reflecting a decrease of 35.2%[19] - The company reported a decrease in cash and cash equivalents at the end of the period to 219,264,438.87 from 250,394,464.93, a decline of 12.4%[20] Assets and Liabilities - Total assets increased by 4.74% to ¥4,801,791,336.89 from ¥4,584,642,439.60 at the end of the previous year[4] - Total current assets increased to ¥1,995,669,692.98, up 3.6% from ¥1,926,628,733.72[13] - Total non-current assets rose to ¥2,806,121,643.91, an increase of 5.6% from ¥2,658,013,705.88[13] - Total liabilities increased to ¥3,745,379,941.57 from ¥3,535,054,457.65, reflecting a growth of 6.0%[14] - Total equity attributable to shareholders increased slightly to ¥940,338,801.43 from ¥934,520,860.62[14] - Short-term borrowings rose to ¥936,175,706.64, an increase of 9.0% from ¥858,908,905.51[13] Operating Costs and Expenses - Total operating costs decreased to ¥444,546,975.37 from ¥489,325,184.95, reflecting a reduction of 9.1%[17] - Research and development expenses increased to ¥12,933,755.51, up 38.4% from ¥9,337,462.07 in the previous period[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 75,062, with the largest shareholder holding 24.78% of the shares[9] - The company did not report any changes in the participation of major shareholders in margin trading or securities lending activities[10] Other Income - The company reported a government subsidy of ¥5,487,724.66, which positively impacted the financial results[5] - The company reported a net investment income of ¥305,879.63, compared to a loss of ¥214,985.56 in the previous period[17] - The company recorded other comprehensive income after tax of 263,944.34, down from 722,025.73, indicating a decrease of 63.5%[18] Revenue from Products - The revenue from dairy products and food maintained a growth trend, increasing by 3.09% year-on-year, despite a decline in trade business revenue[7]

Core Insights - The company reported a revenue of 446 million yuan for the first quarter of 2025, representing a year-on-year decline of 6.90% [1] - The net profit for the same period was 5.6834 million yuan, showing a year-on-year increase of 10.05% [1] Financial Performance - Revenue for Q1 2025: 446 million yuan, down 6.90% compared to the previous year [1] - Net profit for Q1 2025: 5.6834 million yuan, up 10.05% year-on-year [1]

Core Viewpoint - Huangshi Group (002329) reported disappointing financial results for 2024, with significant declines in revenue and net profit compared to the previous year [1][2]. Financial Performance - Total revenue for 2024 was 2.046 billion yuan, a decrease of 29.21% year-on-year [2]. - The net profit attributable to shareholders was -681 million yuan, representing a decline of 1110.73% year-on-year [1][2]. - In Q4 2024, total revenue was 536 million yuan, down 17.11% year-on-year, and the net profit attributable to shareholders was -666 million yuan, a decrease of 519.19% [1]. Key Financial Ratios - Gross margin improved to 24.41%, an increase of 30.6% year-on-year [2]. - Net margin was -33.41%, a decline of 1454.58% year-on-year [2]. - The ratio of selling, general, and administrative expenses to revenue was 24.56%, up 9.46% year-on-year [2]. Cash Flow and Debt Situation - The liquidity ratio was 0.82, indicating increased short-term debt pressure [1][4]. - Cash and cash equivalents represented only 9.77% of total assets, and 24.28% of current liabilities [4]. - The company’s interest-bearing debt ratio reached 45.69% [4]. Changes in Financial Items - Management expenses decreased by 40.48% due to reduced stock incentive costs and the exclusion of a subsidiary from the consolidated financial statements [2]. - Research and development expenses increased by 47.21% as the company focused on new product development [2]. - Cash flow from operating activities decreased by 19.67% due to the exclusion of certain subsidiaries from the consolidated financial statements [2]. Business Model and Financing - The company has relied heavily on marketing-driven performance, which requires careful examination of the underlying drivers [3]. - Since its listing, the company has raised a total of 2.124 billion yuan and distributed 187 million yuan in dividends, resulting in a dividend-to-financing ratio of 0.09 [3].

Core Viewpoint - Huangshi Group has reported a revenue of 2.046 billion yuan for 2024, with a 4.74% year-on-year growth in the dairy segment and a 4.54 percentage point increase in gross margin, solidifying its position as a leader in the domestic water buffalo milk market [1][2] Group 1: Financial Performance - The company achieved an annual revenue of 2.046 billion yuan in 2024 [1] - The dairy segment's revenue grew by 4.74% year-on-year [1] - Gross margin improved by 4.54 percentage points compared to the previous year [1] Group 2: Strategic Initiatives - Huangshi Group introduced 10,000 high-yield water buffalo embryos from Pakistan, addressing a 60-year stagnation in domestic genetic resources [1] - The company has established modern farms in regions such as Guangxi and Hunan [1] - Huangshi Group is the only company globally with the qualification to export high-yield water buffalo embryos to China, creating a competitive advantage in the supply chain [1] Group 3: Research and Development - In 2024, the company increased its R&D investment by 26.8% to 7.3 million yuan [2] - The company employs a "basic research + applied innovation" dual-driven strategy to build a comprehensive innovation system covering the entire industry chain [2] - Huangshi Group is focusing on three key areas for technological breakthroughs, aiming to transform the niche market of water buffalo milk into mainstream demand [2]